Antibodies
Search 
 
Products Site Search
Advanced Search Login Cart
ホーム 会社案内 製品案内 ポスター集 学術情報 お問い合わせ

PE anti-mouse B7-H4 (B7S1, B7X)
Material Safety Data Sheet (MSDS)     Product Data Sheet (HTML)     Product Data Sheet (PDF)     Email this to a friend
PE Anti-mouse B7-H4 (B7S1, B7X) Antibody
128107 50 µg ¥22,400     
128108 200 µg ¥73,400     
Clone: clone 9
Isotype: Rat IgG1
Reactivity: Mouse
Immunogen: B7-S1 Fc fusion protein
Formulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation: The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions. The solution is free of unconjugated PE and unconjugated antibody.
Storage & Handling: The antibody solution should be stored undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.
Application: FC - Quality tested
Recommended Usage: Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For immunofluorescent staining, the suggested use of this reagent is ≤ 1.0 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.


Mouse B7-H4 transfected 293E cells stained with clone 9 PE


Description:

B7-H4 is a newly discovered B7 family member that negatively regulates T cell immunity by inhibiting of T cell proliferation, cytokine production, and cell cycle progression. In vitro, B7-H4 inhibits CD4+ and CD8+ T cell proliferation, cytokine production, and generation of alloreactive cytotoxic T-cells (CTLs). In vivo, blockade of endogenous B7-H4 by specific monoclonal antibody promotes T cell responses. A new function of B7-H4 was reported as an important negative regulator of innate immunity through growth inhibition of neutrophils. It was reported that B7-H4 does not constitutively expressed on peripheral tissues but could be induced to express on T cells, B cells, macrophages, and dendritic cells. B7-H4 is expressed on some tumor cancer cells. The role of B7-H4 in tumor progression may be to transform precancerous cells and then protect them from immunosurveillance. Although B- and T- lymphocyte attenuator (BTLA) was proposed to be the receptor for B7-H4, further studies are needed to identify the inhibitory receptor of B7-H4.

Other Names: B7H4, B7S1, B7-S1, B7x
Structure: Belong to the B7 family of costimulatory proteins and contain two extracellular Ig-like domains.
Distribution: Induced to express on T cells, B cells, macrophages, and dendritic cells. It is also expressed on some tumor cancer cells.
Function: Inhibit T cell activation, cell cycle progression, and cytokine production.
Ligand Receptor: A putative receptor on T cells
PE Rat IgG1, κ Isotype CtrlRTK2071FC,ICFC
Cell Staining Buffer (FBS)FC,ICC,ICFC
RBC Lysis Buffer (10X)FC,ICFC
BioLegend - Home | Company |  Products | Pathways |  Support | Ordering |  Careers | Contact |  Distributors | Sitemap |     
Copyright © 2010 BioLegend, Inc. All rights reserved.